Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2010 Mar 31;66(Pt 4):448–451. doi: 10.1107/S1744309110006081

Crystallization of the pneumococcal autolysin LytC: in-house phasing using novel lanthanide complexes

Inmaculada Pérez-Dorado a, Reyes Sanles a, Ana González b, Pedro García b,c, José L García b, Martín Martínez-Ripoll a, Juan A Hermoso a,*
PMCID: PMC2852341  PMID: 20383019

The complete pneumococcal autolysin LytC has been crystallized by the hanging-drop vapor-diffusion method. A SAD data set has been collected in-house from a Gd derivative up to 2.6 Å resolution.

Keywords: autolysins, LytC, Gd-HPDO3A

Abstract

LytC, one of the major autolysins from the human pathogen Streptococcus pneumoniae, has been crystallized as needles by the hanging-drop technique using 10%(w/v) PEG 3350 as precipitant and 10 mM HEPES pH 7.5. LytC crystals were quickly soaked in mother liquor containing 2 mM of the complex Gd-HPDO3A to produce derivatized crystals (LytCGd-HPDO3A). Both native LytC and isomorphous LytCGd-HPDO3A crystals were flash-cooled in a nitrogen flow at 120 K prior to X-ray data collection using an in-house Enraf–Nonius rotating-anode generator (λ = 1.5418 Å) and a MAR345 imaging-plate detector. In both cases, good-quality diffraction patterns were obtained at high resolution. LytCGd-HPDO3A crystals allowed the collection of a SAD X-ray data set to 2.6 Å resolution indexed in terms of a P21 monoclinic unit cell with parameters a = 59.37, b = 67.16, c = 78.85 Å, β = 105.69°. The anomalous Patterson map allowed the identification of one heavy-atom binding site, which was sufficient for the calculation of an interpretable anomalous map at 2.6 Å resolution.

1. Introduction

Most bacterial species examined contain several murein hydrolases that can degrade or remodel the cell wall. In the case of Streptococcus pneumoniae up to five enzymes that cleave different covalent bonds in peptidoglycan and (lipo)teichoic acids have been described (López & García, 2004; Eldholm et al., 2009). Nevertheless, only two of them (LytA and LytC) are responsible for causing lysis and death of the cell and consequently are properly named autolysins. LytC is a lysozyme that specifically provokes autolysis of the pneumococci when growing at 303 K (García et al., 1999). LytC belongs to the family of so-called choline-binding proteins (CBPs), which are attached to the bacterial surface through noncovalent interactions with the phosphorylcholine residues that are present in teichoic and lipoteichoic acids (López & García, 2004). Some of these pneumococcal murein hydrolases play important roles in pathogenesis, although their precise function is still unknown (Gosink et al., 2000). S. pneumoniae is an important human pathogen with great morbidity and mortality, especially among children and the elderly. In the last two decades, the rise of resistance to penicillin and other antibiotics has triggered a search for new pharmacological targets and the development of innovative weapons. In this regard, the use of cell-wall lytic enzymes from pneumococcal phages such as Cpl-1 or Pal (termed enzybiotics) has yielded promising results to date in the eradication of pneumoccocal infections using animal models (Jado et al., 2003; McCullers et al., 2007). The results presented here constitute an advance towards the structural characterization of LytC, an autolysin and a virulence factor in S. pneumoniae (Gosink et al., 2000) and therefore a potential pharmacological target.

A SAD X-ray data set was collected in-house (Cu Kα radiation) from the LytCGd-HPDO3A derivative. Data processing showed the existence of a good-quality anomalous signal that led to the identification of a single Gd-binding site per asymmetric unit. This single heavy atom was sufficient for the calculation of an initial anomalous map at 2.6 Å resolution, which is currently being used for structural modelling of LytC. Detailed structure determination will help in understanding the function of this enzyme and could open new thera­peutic prospects for treating pneumococcal diseases.

2. Experimental procedures

2.1. Protein expression and purification

The mature form of the pneumococcal LytC lysozyme (55 210 Da) was expressed in Escherichia coli BL21 (DE3) [pLCC14] strain (García et al., 1999). This cell culture was grown at 310 K with aeration. At an OD600 of about 0.4–0.5, protein expression was induced with 40 µM isopropyl β-d-1-thiogalactopyranoside and incubation was continued at 293 K for 3 h to minimize the presence of inclusion bodies. Cells were collected by centrifugation, resuspended in 20 mM sodium phosphate buffer pH 6.0 and disrupted in a French pressure-cell press (7.6 MPa) at 277 K. The supernatant was loaded onto a DEAE-cellulose column and washed with three volumes of 20 mM sodium phosphate buffer pH 6.0 containing 1.5 M NaCl. The same buffer containing 2% choline was then added and pure LytC was recovered. Thus, DEAE-cellulose acts to purify CBPS by affinity chromatography, as has been demonstrated previously (Sánchez-Puelles et al., 1992; García et al., 1999). The eluted fractions of the protein with the highest purity were pooled and dialyzed against a buffer containing 20 mM Tris–HCl pH 8.0 and 200 mM choline using a PD-10 Desalting column from Amersham Pharmacia Biotech. Dialyzed protein samples were concentrated at 277 K using a 10 kDa cutoff protein concentrator (Amicon, YM-10) to the values required for crystallization assays (between 8 and 12 mg ml−1). Under these conditions, LytC precipitated after freezing at 269 K or after several freeze–thaw cycles. Thus, in order to minimize protein degradation, samples were aliquoted and stored at 193 K and those aliquots that were thawed for crystallization trials were maintained at 277 K. The protein concentration was estimated by UV spectrophotometry using a molar absorption co­efficient of 196 150 M −1 cm−1 at 280 nm.

2.2. Crystallization and heavy-atom derivatization

An extensive screening to identify crystallization conditions for LytC was performed using commercial screening kits from Hampton Research (Crystal Screen I, Crystal Screen II and Index). Initial trials were performed by the sitting-drop vapour-diffusion method at 291 K using high-throughput techniques with a Quat-Z 215 robot from Gilson. 250 nl droplets were formed by mixing 125 nl protein solution at 12 mg ml−1 and 125 nl precipitant solution. Initial crystals were obtained using condition No. 61 of Index screen, which consisted of 10%(w/v) PEG 3350, 100 mM HEPES pH 7.5 and 200 mM proline. Crystallization conditions were subsequently scaled up using the hanging-drop vapour-diffusion method at 291 K; 2 µl droplets (1 µl protein solution and 1 µl precipitant solution) were equilibrated against 500 µl reservoir solution. After scaling, optimization trials yielded a final condition consisting of 2 µl droplets formed by mixing 1 µl protein solution at 8 mg ml−1 and 1 µl precipitant solution [10%(w/v) PEG 3350 and 10 mM HEPES pH 7.5]. LytC crystals obtained under these conditions reached maximum dimensions of 0.8 × 0.1 × 0.1 mm in 10–15 d (see Fig. 1). These crystals will be referred to as LytCNATIVE. Heavy-atom derivatization was carried out by soaking experiments using the gadolinium complex Gd-HPDO3A (Girard et al., 2003). In these experiments, LytCNATIVE crystals were soaked in 2 µl droplets of mother liquor containing various concentrations of Gd-HPDO3A. High concentrations of the Gd complex (>25 mM) and long soaking times generated crystal cracking or a loss of crystal order. In order to minimize this damage, several trials were performed until the optimum conditions were found. These conditions consisted of a 1–2 s soak in mother-liquor solution containing 2 mM Gd-HPDO3A. Crystals of LytC derivatized with Gd-HPDO3A will be referred as LytCGd-HPDO3A.

Figure 1.

Figure 1

Crystals of wild-type LytC. The crystals grew at 291 K in 10%(w/v) PEG 3350 and 10 mM HEPES pH 7.5.

2.3. X-ray data collection and processing

LytCGd-HPDO3A crystals were tested and diffraction data were collected using Cu Kα (λ = 1.5418 Å) radiation generated by an in-house Enraf–Nonius FR591 rotating-anode generator operated at 40 kV and 60 mA and equipped with a Helios double-mirror focusing system (Bruker). X-ray photographs were collected using a MAR345 imaging-plate detector. Prior to X-ray data collection, cryoprotected crystals were captured in nylon loops and flash-cooled in a nitrogen flow at 120 K. The cryoprotectant solution used contained 10%(w/v) PEG 3350, 10 mM HEPES pH 7.5, 20%(v/v) glycerol and 2 mM Gd-­HPDO3A. X-ray data were processed and reduced using the programs MOSFLM (Leslie, 1992) and SCALA from the CCP4 package (Collaborative Computational Project, Number 4, 1994).

The large anomalous signal of gadolinium accessible using Cu Kα radiation (f′′ = 12 e; see Fig. 2 a) makes Gd extremely useful for phasing using in-house X-ray sources. The use of gadolinium derivatives in the structural resolution of the choline-binding proteins (CBPs) Pce (Lagartera et al., 2005) and CbpF (Molina, González et al., 2009) has previously been reported; the Gd-HPDO3A derivative (Girard et al., 2003) was used in both these cases. This compound consists of a central Gd atom coordinated by a macrocyclic tetraazacyclododecane (Fig. 2 b). The affinity of Gd-HPDO3A for choline-binding sites means that it should be useful in the phasing of other CBPs (Molina, Stelter et al., 2009). Anomalous signal estimation was performed with the program SHELX (Sheldrick, 2008).

Figure 2.

Figure 2

(a) Absorption edges for the Gd atom. (b) Schematic representation of the HPDO3A macrocycle.

3. Results and discussion

Good-quality and high-resolution X-ray diffraction patterns were measured for both LytCNATIVE and the isomorphous LytCGd-HPDO3A crystals using Cu Kα radiation generated by an in-house rotating-anode generator. The best LytCGd-HPDO3A crystal allowed us to collect a SAD X-ray data set to 2.6 Å resolution (Fig. 3). Automatic indexing of the diffraction images of this derivative identified the space group as primitive monoclinic (P2 or P21), with unit-cell parameters a = 59.37, b = 67.16, c = 78.85 Å, β = 105.69°. Integrating and scaling the diffraction data in space group P2 yielded an overall R merge value of 0.11 (Table 1), confirming the space-group symmetry. Systematic absences along 0k0 of k = 2n indicated the space group to be P21. Calculation of the Matthews coefficient revealed a solvent content of 55% for a single molecule in the asymmetric unit (V M = 2.74 Å3 Da−1; Matthews, 1968). An anomalous Patterson map calculated for the entire X-ray data set displayed one single and clear peak of 6.5σ, indicating the presence of a single Gd atom in the asymmetric unit (two Gd atoms per unit cell). Analysis of the values obtained from SHELXC (Sheldrick, 2008) revealed anomalous signal to 3.3 Å resolution. Structural modelling and refinement is currently in progress.

Figure 3.

Figure 3

1° oscillation image of a LytCGd-HPDO3A crystal.

Table 1. Data-collection statistics for LytC crystals.

Values in parentheses are for the highest resolution shell.

Crystal data  
 Space group P21
 Unit-cell parameters  
   a (Å) 59.37
   b (Å) 67.16
   c (Å) 78.85
  β (°) 105.69
Data collection  
 Wavelength (Å) 1.5418
 Temperature (K) 120
 Resolution (Å) 30.57–2.57 (2.71–2.57)
 Total No. of reflections 124908
 No. of unique reflections 18467
  Centric 1038 (24)
  Acentric 17429 (218)
 Redundancy 6.7 (6.7)
 Anomalous redundancy 3.5 (3.4)
 Completeness (%) 99.4 (99.0)
 Anomalous completeness (%) 99.3 (98.7)
I/σ(I) 14.8 (3.8)
Rmerge 0.12 (0.49)
Rano 0.07 (0.22)

Parameters provided by SCALA.

R merge = Inline graphic Inline graphic.

In summary, in-house SAD experiments have allowed us to calculate initial anomalous maps using a single Gd atom per polypeptide chain. These results reflect not only the utility of these lanthanide derivatives for in-house macromolecular phasing, but also the excellent quality of the anomalous signal obtained, which enabled us to phase a 55 210 Da protein using a single heavy atom.

Acknowledgments

The authors thank Bracco Imaging (Milan) for kindly providing a sample of Gd-HPDO3A. This work was supported by grants from the Spanish Ministry of Science and Technology (BFU2008-01711, SAF2006-00390 and the Factoría de Cristalización from the CONSOLIDER-INGENIO 2010 program), EU-CP223111 (CAREPNEUMO, European Union). CIBER de Enfermedades Respiratorias is an initiative of Spanish Instituto de Salud Carlos III. IP-D and SR were granted I3P-CSIC and FPI fellowships, respectively.

References

  1. Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50, 760–763.
  2. Eldholm, V., Johnsborg, O., Haugen, K., Ohnstad, H. S. & Havarstein, L. S. (2009). Microbiology, 155, 2223–2234. [DOI] [PubMed]
  3. García, P., González, M. P., García, E., García, J. L. & López, R. (1999). Mol. Microbiol.33, 128–138. [DOI] [PubMed]
  4. Girard, É., Stelter, M., Vicat, J. & Kahn, R. (2003). Acta Cryst. D59, 1914–1922. [DOI] [PubMed]
  5. Gosink, K. K., Mann, E. R., Guglielmo, C., Tuomanen, E. I. & Masure, H. R. (2000). Infect. Immun.68, 5690–5695. [DOI] [PMC free article] [PubMed]
  6. Jado, I., López, R., García, E., Fenoll, A., Casal, J. & García, P. (2003). J. Antimicrob. Chemother.52, 967–973. [DOI] [PubMed]
  7. Lagartera, L., González, A., Stelter, M., García, P., Kahn, R., Menéndez, M. & Hermoso, J. A. (2005). Acta Cryst. F61, 221–224. [DOI] [PMC free article] [PubMed]
  8. Leslie, A. G. W. (1992). Crystallographic Computing 5: From Chemistry to Biology, edited by D. Moras, A. D. Podjarny & J. C. Thierry, pp. 39–50. Oxford University Press.
  9. López, R. & García, E. (2004). FEMS Microbiol. Rev.28, 553–580. [DOI] [PubMed]
  10. Matthews, B. W. (1968). J. Mol. Biol.33, 491–497. [DOI] [PubMed]
  11. McCullers, J. A., Karlstrom, A., Iverson, A. R., Loeffler, J. M. & Fischetti, V. A. (2007). PLoS Pathog.3, e28. [DOI] [PMC free article] [PubMed]
  12. Molina, R., González, A., Stelter, M., Pérez-Dorado, I., Kahn, R., Morales, M., Moscoso, M., Campuzano, S., Campillo, N. E., Mobashery, S., García, J. L., García, P. & Hermoso, J. A. (2009). EMBO Rep.10, 246–251. [DOI] [PMC free article] [PubMed]
  13. Molina, R., Stelter, M., Kahn, R. & Hermoso, J. A. (2009). Acta Cryst. D65, 823–831. [DOI] [PubMed]
  14. Sánchez-Puelles, J. M., Sanz, J. M., García, J. L. & García, E. (1992). Eur. J. Biochem.203, 153–159. [DOI] [PubMed]
  15. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES